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LC-MS analysis of UFM1 probes S21 Figure S10 ). [1] . Asterisks (*) denote the labeled enzymes. Cat#8521150005 CAS 900152-72-9). In the case of the UFM1-PA probe, Gly83 was omitted to allow coupling of propargylamine, which was performed as described previously [2] .
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Figure S2: A) UV-traces of the FMOC deprotection during linear SPPS synthesis of UFM1. Red arrow indicates major inefficient coupling-position and start of synthesis is indicated by a black arrow. To circumvent this issue, we synthesized two fragments: a N-terminal fragment (AA 1-44) and a C-terminal fragment (AA 45-83) and ligated them using native chemical ligation (NCL). (LC-MS analysis of UFM1-PA generated by linear synthesis is shown in
Figure S5: Competition experiments reveal preference for UFM1-PA over UFM1-Dha. A) Fluorescence scan showing that only a minor portion of ectopically overexpressed Flag-Ufsp1 reacts with Rho-UFM1-Dha (8). B) Corresponding immunoblot against the Flag-tagged protease reveals that the enzyme prefers UFM1-PA (9) over Rho-UFMDha (8), as becomes clear after prolonged exposure of the immunoblot. Differences in reactivity of Ufsp1 towards UFM1-PA and UFM1-Dha may be due to the unique active-site configuration of this protease
Native Chemical Ligation Strategy
Solid Phase Peptide Synthesis (SPPS) was performed using standard 9- were added after which the pH was adjusted to 7.6. The reaction was agitated at 37 0 C for 30 min after which LC-MS analysis showed complete consumption of the Nterminal thioester and formation of the NCL-product.
Desulphurisation reactions:
The reaction was diluted to 10 mL in water and spun down using an Amicon spinfilter (MWCO 10 kD) to 1 mL. This procedure was repeated two times after which the remaining suspension was taken up in 4 mL (Gdn•HCl (8M)/ TCEP (1M), 4:1 v/v).
Glutathione (32 mg/mL) and VA044 (31 mg/mL) were added, the pH adjusted to 6.5
and desulphurization was accomplished by agitation overnight at 37 0 C. HPLC purification followed by lyophilisation of the appropriate fractions, followed by SEC purification using 20 mM TRIS, 150 mM NaCl buffer at pH 7.6 yielded the final compounds.
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RP-HPLC purifications
Shimadzu semi-preparative RP-HPLC system, equipped with a Waters C18-Xbridge 5 µm OBD (10 x 150 mm) column at a flowrate of 6.5 mL/min. using 2 mobile phases:
A: MQ + 0.05% TFA, B: CH3CN + 0.05 % TFA. Gradient: 10 -> 70% B.
Gel filtration
Size Exclusion Chromatography was performed on a Sephadex S75 10/300 column (GE Healthcare), using a 20 mM TRIS, 150 mM NaCl buffer at pH 7.6. Appropriate fractions were pooled and concentrated using an Amicon spinfilter (MWCO 10 kD) to a final concentration of ca. 1 mg/mL
LC-MS measurements:
Waters 2795 Separation Module (Alliance HT) using a Phenomenex Kinetex C18-column (2.1x50, 2.6 μm), Waters 2996 Photodiode Array Detector (190-750 nm) and LCT TM ESI-Mass Spectrometer. Samples were run using 2 mobile phases: A = 1% CH3CN, 0.1% formic acid in water and B = 1% water and 0.1% formic acid in CH3CN.
Flow rate= 0.8 mL/min, runtime= 6 min, column T= 40°C. Gradient: 0 -95% B. Data processing was performed using Waters MassLynx Mass Spectrometry Software 4.1
(deconvolution with MaxEnt1 function).
HRMS-measurements:
High resolution mass spectra were recorded on a Waters Acquity H-class UPLC with XEVO-G2 XS Q-TOF mass spectrometer equipped with an electrospray ion source in Validation of the structural integrity of our synthetic UFM1 was done using circular dichroism (CD). After dissolving synthetic UFM1 (40 mg/mL) in DMSO, it was diluted into ddH2O, vortexed briefly and added to 20 mM sodium phosphate buffer (pH 7.0) and buffer exchanged to 20 mM sodium phosphate buffer (pH 7.0) using a 3 kDa cutoff Amicon Ultra-15 Centrifugal Filter Unit (Millipore). In case of the expressed UFM1 and the UFM1 generated by native chemical ligation, proteins were directly buffer exchanged into 20mM sodium phosphate buffer (pH 7.0) using a 3 kDa cut-off Amicon Ultra-15 Centrifugal Filter Unit (Millipore). Final concentrations of synthetic and expressed UFM1 were determined by gel-quantification. Circular dichroism was measured using a JASCO J-815 CD Spectrometer at 25°C using samples diluted to approximately 10 µM final concentration. CD spectra were recorded ranging from 250
to 190 nm at a scan rate of 20 nm per minute and a scan width of 1 nm using a quartz cuvette with a 1 mm path length. Three cumulative measurements were averaged and plotted using Graphpad PRISM.
Protein expression and purification
UFM1 and UBA5 were expressed as N-terminal His-SUMO fusions in E. coli BL21(DE3) using autoinduction [3] . After reaching OD600 0.6, the temperature was lowered to 18°C and the bacteria were grown an additional 18h. Enzymes were purified using TALON beads (Clontech) equilibrated in Buffer A (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM DTT), washed twice with Buffer A and eluted with 100mM imidazole (pH 7.5) For further purification, the enzymes were subjected to anion exchange (Resource Q, GE Healthcare) with a gradient of 1 M NaCL in Buffer A, followed by size exclusion chromatography (S75, 16/600, GE Healthcare). In the case of UFM1, the N-terminal His-SUMO tag was cleaved by incubation with 5 µM SENP2 for 1h at 4°C, followed by further purification using TALON beads (Clontech) and size exclusion chromatography using a Superdex S75 16/600 column (GE Healthcare).
Pure proteins were concentrated, aliquoted, flash frozen in liquid nitrogen, and stored at -80°C.
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Constructs
Murine Ufsp1 was subcloned into a 2xFLAG-C1 vector (Clontech) at BglII/PstI restriction sites. Similarly, human Ufsp2 amplified from cDNA was cloned into a GFP-C1 vector (Clontech) at EcoRI/XhoI sites. UFM1 and UBA5 were amplified from cDNA, and cloned into an N-terminal His6-SUMO LIC vector according to the standard protocol. The active-site cysteine (C53) in murine Ufsp1 was mutated to alanine according to the protocol of the Quik Change Site-directed Mutagenesis Kit (Invitrogen). All constructs were verified by sequencing. Human Ufsp1 was amplified from cDNA and cloned into a 2x-Flag-C1 vector (Clontech) using BglII/ PstI restriction sites.
Mammalian cell lines
HEK293T and HeLa cell lines used in this study originated from ATCC and were cultured under standard conditions in DMEM (Gibco) supplemented with 10% FCS (Sigma-Aldrich) at 37°C with 5% CO2. CRISPR-mediated Ufsp2 depletion in Hela cells was performed by co-transfecting confluent HeLa with a vector harbouring the gRNA and the Cas9 and a construct conferring blasticidin resistance [4] . After blasticidin selection and clonal expansion, Ufsp2 depletion was verified immunoblotting against using anti-Ufsp2 antibody (1:1000 dilution, Abcam ab185965). Ufsp2 guide RNA (gRNA) was designed using the CRSIPR Design tool (http://crispr.mit.edu/), subcloned into a pX330-U6-Chimeric-BB-CBh-hSpCas9 vector (Addgene, plasmid # 42230) [5] .
All cell lines were routinely tested for mycoplasma contamination with consistently negative outcome.
Labeling of purified enzymes
Thioester-formation of His-SUMO-UBA5 and UFM1, Rho-UFM1 or UFM1-Dha were assessed by incubating 1µM of His-SUMO-UBA5 with 5µM UFM1 in labeling buffer (50 mM Bis-Tris, pH 6.5, 100 mM NaCl, 10 mM MgCl2, 0.1 mM DTT and 0.4 mM ATP)
at 30°C for 30 min. Reactions were quenched by addition of 3x SDS-PAGE loading Dye without addition of reducing agents and subsequently resolved by standard SDS-PAGE gel electrophoresis. Enzymes were visualized by in-gel fluorescence scanning (λem / λex = 480/530 nm) followed by Coomassie staining. Labeling of recombinant His6-UBE1 with Ub-Dha or UFM1-Dha was performed as described previously [6] .
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Labeling of overexpressed enzymes in cell lysates
For overexpression of UFM1 specific proteases and DUBs, Flag-Ufsp1 and the GFPtagged DUBs [2] were transfected into HEK293T cells using polyethylenimine (PEI, 
Electroporation experiments
For electroporation experiments, 80.000 HeLa cells were seeded into a 6-well plate and transfected with murine Flag-Ufsp1 and the corresponding catalytically inactive mutant using Effectene (Qiagen), according to the manufacturer's instructions. To facilitate the incorporation of the probe, the growth medium was replaced 4-6 h after S19 transfection and refreshed again 1-2 h prior to electroporation. Following removal of the growth medium, cells were kept on ice for the duration of the protocol. Cells were washed twice with cold electroporation buffer (2 mM HEPES, pH 7.4, 15 mM K2HPO4/KHPO4, 250 mM mannitol, 1 mM MgCl2). 1.5 mL of a solution of Rho-UFM1
(or Rho-UFM1-PA, Rho-UFM1-Dha) in electroporation buffer (0.4 mg/mL) was added to each of the wells and electroporation was performed on ice using a Biorad
GenePulser Xcell with CE and PE module Pulse Generator equipped with a Petri
Pulser electroporation applicator (BTX) using the following settings: square wave, voltage = 75V, pulse length = 3ms, pulse interval = 1.5s, number of pulses = 5, cuvette width = 2 mm. The electroporation applicator was turned 90 degrees, and electroporation was repeated once. The probe solution was replaced by cold electroporation buffer, and cells were allowed to recover on ice for 2 min. After electroporation, cells were washed twice with ice-cold PBS and allowed to recover for 120 min under standard growth conditions. For gel-based analysis, samples were lysed using reducing SDS-PAGE loading buffer followed by brief sonication and heating at 98°C for 10 min before being separated on SDS-PAGE gel followed by visualization by fluorescence scanning (λex / λem = 480/530 nm). Subsequently, western-blotting was performed as previously described, and membranes were probed with mouse anti-Flag (1:1000 dilution, Sigma) and mouse anti-β-actin (1:10000 dilution, Sigma).
Confocal microscopy. For microscopy experiments, the samples were fixed in 4%
formaldehyde (Merck) in PBS and mounted onto glass slides (Thermo Scientific) using Prolong Gold mounting medium with DAPI (Invitrogen). Images were collected on a Leica SP8 confocal microscope equipped with HyD detectors, using a 63x oilimmersion magnification lens in combination with 2-4x digital zoom. Image processing and fluorescence intensity analysis were performed using ImageJ software and expressed in the form of Mander's overlap coefficients calculated using JaCoP. 
Figure S12: (HR)LC-MS analysis of Rho-UFM1-PA prepared by linear SPPS. Total Ion Count spectrum (top panel), ESI-MS spectrum (middle) and the deconvoluted mass (bottom panel
